Intrasense is pleased to present the new version 2.9, with a focus on new clinical features.

Intrasense announces its 2020 IFRS Group consolidated annual results.

Intrasense and MeVis Medical Solutions AG specialized in
the development of clinical applications integrating artificial intelligence, announce a global partnership in the field of lung diseases.

Intrasense announces the publication of its half year liquidity contract signed with TSAF – Tradition Securities And Futures.

Intrasense strengthens its management team with the appointment of Khalil Filali as Group Chief Business Officer.